News & Analysis on Clinical Trial Services & Contract Research And Development
Chiltern, Patheon, Hill Top Research, AMRI, Perceptive Informatics, Xceleron and Charles River Labs have all had people on the move in the world of pharmaceutical outsourcing.
Italian firm Cosmo Pharmaceuticals has announced positive preliminary results from trials testing out a new formulation of an antibioticfor traveller's diarrhoea that makes use of the company's innovative MMX technology.
Procter & Gamble (P&G) Pharmaceuticals has penned a deal worth up to $511m (€375m) for a class of potential osteoporosis drugs already well established as asthma therapies.
NPS Pharmaceuticals has sold two facilities and appointed a new COO as part of a recently revealed restructuring strategy to rely more on outsourcing.
Australia is soon to boast the largest monoclonal antibody production facility in the Southern Hemisphere, which will go some way in alleviating the increasing demand for the biologic agents.
New research provides some insight into what motivates patients to participate in clinical trials and how the experience could be improved for them.
NPS Pharmaceuticals, Targanta Therapeutics, Merck & Co., MAP Pharmaceuticals and Merrimack Pharmaceuticals have all had people on the move in the world of pharmaceutical manufacturing.
Aussie drug delivery firm Acrux has reported positive results from trials of its novel transdermal spray, tested for the first time with a combination contraceptive formulation.